Neurodegenerative Diseases

Merck Collaborates with Yumanity to Accelerate the Development of Two Therapies Targeting Neurodegenerative Diseases

June 25, 2020June 25, 2020Tuba Khan

Shots: Yumanity will receive $500M upfront and milestones along with royalties on net sales of therapies, in exchange Merck to get an exclusive [Read More...]

MSD Signs a Two-Year Research Agreement with Almac to Discover DUB Therapeutic Targets for Neurodegenerative Diseases

April 30, 2020April 30, 2020Tuba Khan

Shots::stosohSthShots: Almac to receive upfront, research funding, development and commercial milestones along with the royalties on sales of products emerging from the collaboration. [Read More...]

Prevail Signs an Agreement with Lonza to Develop and Manufacture AAV9 Gene Therapy Programs for Patients with Neurodegenerative Diseases

October 9, 2019October 9, 2019Shiwani Sharma

Shots: Pevail and Lonza to work collaboratively for process and analytical development plus large-scale production using the baculovirus/Sf9 process for late-stage clinical and [Read More...]

Regenxbio Signs an Exclusive Development and Commercialization Agreement with Neurimmune for AAV Gene Therapies Targeting Neurodegenerative Diseases

July 25, 2019July 25, 2019Tuba Khan

Shots: Regenxbio and Neurimmune enter into a collaboration to develop vectorized Ab by combining antibodies identified using Neurimmune’s reverse translational medicine platform with [Read More...]